Sentence examples for mutation versus from inspiring English sources

There was no apparent survival difference with EGFR-activating mutations versus wild type or KRAS mutation versus wild type.Survival of poor-risk patients with wild type or mutated EGFR receiving sequential CRT with gefitinib was promising.

To investigate the role(s) of colony-stimulating factor 1 (CSF-1) on the development of early endometriosis in a murine model by comparing rate of lesion formation in mice [1] homozygous for a CSF-1 mutation versus syngeneic controls and [2] after treatment with imatinib, a commercially available tyrosine kinase inhibitor that alters interaction(s) between CSF-1 and its receptor, c-fms.

As Foley sees it, the question of mutation versus extinction is a no-brainer.

For PI, 38% of subtype B isolates presented at least one primary resistance mutation versus only 8% of subtype C isolates (p = 0.0037, Fisher's exact test).

Here, the relative occurrence of a transitional mutation versus a transversional mutation (r) was set to be 4.0 (the expected ratio in the numbers of transitional and transversional mutations was 2.0).

Median OS for patients with BRAF mutation versus NRAS mutation versus wild-type were: 21.9 versus 15.1 versus 43.3 months, respectively.

Shown is the correlation between estimated effective population size and the slope of the regression lines of the ratio between deleterious and tolerated mutations versus their derived allele frequencies for each geographic region.

However, the likelihood that an airborne-transmissible variant evolves upon zoonotic infection or co-infection with zoonotic and seasonal IAVs remains poorly understood, as does the relative importance of accumulating mutations versus re-assortment in this process.

To evaluate intracytoplasmic sperm injection (ICSI) results with regard to congenital bilateral absence of vas deferens (CBAVD) versus non-CBAVD obstruction, cystic fibrosis transmembrane-conductance regulator (CFTR) mutations versus non-CFTR mutations, and miscarriages or stillbirths versus live births per embryo transferred.

We examined 7 of the 270 genes by quantitative PCR and validated that 4 (57%) were differentially expressed between cell lines with L858R mutations versus those with Δ746 750 mutations (File S6).

Among patients with EGFR-mutant NSCLC, differences in survival duration and responsiveness to EGFR TKI treatment have been observed depending on the type of EGFR somatic mutation (exon 21 point mutations versus exon 19 deletions) [22 23], suggesting that these two types of somatic mutations confer distinct biologic properties to NSCLC cells.